INFLIXIMAB IS EFFECTIVE AT PREVENTING RESTENOSIS AFTER THE ENDOSCOPIC BALLOON DILATATION THERAPY IN PATIENT'S WITH CROHN'S DISEASE.

Masayuki Saruta  1     Seiji Arihiro  1     Daisuke Ide  1     Tetsuyoshi Iwasaki  1     Nobuhiko Komoike  1     Yoshinori Arai  1     Hisao Tajiri  1     Tomohiro Kato  1    
1 THE JIKEI UNIVERSITY SCHOOL OF MEDICINE

Session
IBD II

Conference
UEG Week 2013

Citation
United European Gastroenterology Journal; 2013: 1 (Supplement 1) A375


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing